▶ 調査レポート

経皮的薬剤パッチの世界市場レポート2020

• 英文タイトル:Global Transdermal Drug Patches Sales Market Report 2020

が調査・発行した産業分析レポートです。経皮的薬剤パッチの世界市場レポート2020 / Global Transdermal Drug Patches Sales Market Report 2020 / MRC2102QY15234資料のイメージです。• レポートコード:MRC2102QY15234
• 出版社/出版日: / 2021年1月
• レポート形態:英文、PDF、144ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の経皮的薬剤パッチ市場について種類別(フェンタニル経皮パッチ、ニコチン経皮パッチ、ブプレノルフィン経皮パッチ、クロニジン経皮パッチ、オキシブチニン経皮パッチ、その他)、用途別(高血圧用、避妊用、鎮痛用、禁煙用、狭心症用、ホルモン補充用)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・経皮的薬剤パッチ市場の概要
・世界の主要地域別経皮的薬剤パッチ市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の経皮的薬剤パッチ市場規模2015-2026:種類別(フェンタニル経皮パッチ、ニコチン経皮パッチ、ブプレノルフィン経皮パッチ、クロニジン経皮パッチ、オキシブチニン経皮パッチ、その他)
・世界の経皮的薬剤パッチ市場規模2015-2026:用途別(高血圧用、避妊用、鎮痛用、禁煙用、狭心症用、ホルモン補充用)
・経皮的薬剤パッチの米国市場規模2015-2020
・経皮的薬剤パッチのヨーロッパ市場規模2015-2020
・経皮的薬剤パッチの中国市場規模2015-2020
・経皮的薬剤パッチの日本市場規模2015-2020
・経皮的薬剤パッチの東南アジア市場規模2015-2020
・経皮的薬剤パッチのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・経皮的薬剤パッチの製造コスト分析
・販売チャネル、流通業者、顧客
・経皮的薬剤パッチの市場動向・機会・課題
・調査の結論

A transdermal drug patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal patches are presently being marketed which can be worn anywhere from as little as eight hours to as long as seven days, depending on their therapeutic indication.
Transdermal drug patches production has relatively high technology barrier and is technology intensive industry. Currently, there are many producing companies in the USA transdermal drug patches industry. The main market players are Noven, Mylan, Novartis and Johnson & Johnson. The production of transdermal drug patches will increase to 477482 K Units in 2016 from 340530 K Units in 2011 with average growth rate of 7.00%. USA transdermal drug patches capacity utilization rate remained at around 76.86% in 2015.

Market Analysis and Insights: Global Transdermal Drug Patches Market
The global Transdermal Drug Patches market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.

Global Transdermal Drug Patches Scope and Market Size
The global Transdermal Drug Patches market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Drug Patches market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Transdermal Drug Patches market is segmented into
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others

Segment by Application, the Transdermal Drug Patches market is segmented into
Used for Hypertension
Used for Contraception
Used for Analgesia
Used for Smoking Cessation
Used for Angina
Used for Hormone Replacement

The Transdermal Drug Patches market is analysed and market size information is provided by regions (countries). Segment by Application, the Transdermal Drug Patches market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Transdermal Drug Patches Market Share Analysis
Transdermal Drug Patches market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transdermal Drug Patches business, the date to enter into the Transdermal Drug Patches market, Transdermal Drug Patches product introduction, recent developments, etc.

The major vendors covered:
Noven
Mylan
Novartis
Johnson & Johnson
Agile Therapeutics
Teikoku Pharma USA
Immune Pharmaceuticals
Hercon Pharmaceuticals
Pocono
DURECT Corporation
Xel Pharmaceuticals

レポート目次

1 Transdermal Drug Patches Market Overview
1.1 Transdermal Drug Patches Product Scope
1.2 Transdermal Drug Patches Segment by Type
1.2.1 Global Transdermal Drug Patches Sales by Type (2020-2026)
1.2.2 Fentanyl Transdermal Patch
1.2.3 Nicotine Transdermal Patch
1.2.4 Buprenorphine Transdermal Patch
1.2.5 Clonidine Transdermal Patch
1.2.6 Oxybutynin Transdermal Patch
1.2.7 Others
1.3 Transdermal Drug Patches Segment by Application
1.3.1 Global Transdermal Drug Patches Sales Comparison by Application (2020-2026)
1.3.2 Used for Hypertension
1.3.3 Used for Contraception
1.3.4 Used for Analgesia
1.3.5 Used for Smoking Cessation
1.3.6 Used for Angina
1.3.7 Used for Hormone Replacement
1.4 Transdermal Drug Patches Market Estimates and Forecasts (2015-2026)
1.4.1 Global Transdermal Drug Patches Sales Growth Rate (2015-2026)
1.4.2 Global Transdermal Drug Patches Revenue and Growth Rate (2015-2026)
1.4.3 Global Transdermal Drug Patches Price Trends (2015-2026)

2 Transdermal Drug Patches Estimate and Forecast by Region
2.1 Global Transdermal Drug Patches Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Transdermal Drug Patches Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Transdermal Drug Patches Sales Market Share by Region (2015-2020)
2.2.2 Global Transdermal Drug Patches Revenue Market Share by Region (2015-2020)
2.3 Global Transdermal Drug Patches Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Transdermal Drug Patches Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Transdermal Drug Patches Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Transdermal Drug Patches Estimates and Projections (2015-2026)
2.4.2 Europe Transdermal Drug Patches Estimates and Projections (2015-2026)
2.4.3 China Transdermal Drug Patches Estimates and Projections (2015-2026)
2.4.4 Japan Transdermal Drug Patches Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Transdermal Drug Patches Estimates and Projections (2015-2026)
2.4.6 India Transdermal Drug Patches Estimates and Projections (2015-2026)
3 Global Transdermal Drug Patches Competition Landscape by Players
3.1 Global Top Transdermal Drug Patches Players by Sales (2015-2020)
3.2 Global Top Transdermal Drug Patches Players by Revenue (2015-2020)
3.3 Global Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Patches as of 2019)
3.4 Global Transdermal Drug Patches Average Price by Company (2015-2020)
3.5 Manufacturers Transdermal Drug Patches Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Transdermal Drug Patches Players (Opinion Leaders)
4 Global Transdermal Drug Patches Market Size by Type
4.1 Global Transdermal Drug Patches Historic Market Review by Type (2015-2020)
4.1.1 Global Transdermal Drug Patches Sales Market Share by Type (2015-2020)
4.1.2 Global Transdermal Drug Patches Revenue Market Share by Type (2015-2020)
4.1.3 Global Transdermal Drug Patches Price by Type (2015-2020)
4.2 Global Transdermal Drug Patches Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Transdermal Drug Patches Sales Forecast by Type (2021-2026)
4.2.2 Global Transdermal Drug Patches Revenue Forecast by Type (2021-2026)
4.2.3 Global Transdermal Drug Patches Price Forecast by Type (2021-2026)
5 Global Transdermal Drug Patches Market Size by Application
5.1 Global Transdermal Drug Patches Historic Market Review by Application (2015-2020)
5.1.1 Global Transdermal Drug Patches Sales Market Share by Application (2015-2020)
5.1.2 Global Transdermal Drug Patches Revenue Market Share by Application (2015-2020)
5.1.3 Global Transdermal Drug Patches Price by Application (2015-2020)
5.2 Global Transdermal Drug Patches Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Transdermal Drug Patches Sales Forecast by Application (2021-2026)
5.2.2 Global Transdermal Drug Patches Revenue Forecast by Application (2021-2026)
5.2.3 Global Transdermal Drug Patches Price Forecast by Application (2021-2026)

6 United States Transdermal Drug Patches Market Facts & Figures
6.1 United States Transdermal Drug Patches Sales Market Share by Company (2015-2020)
6.2 United States Transdermal Drug Patches Sales Market Share by Type (2015-2020)
6.3 United States Transdermal Drug Patches Sales Market Share by Application (2015-2020)

7 Europe Transdermal Drug Patches Market Facts & Figures
7.1 Europe Transdermal Drug Patches Sales Market Share by Company (2015-2020)
7.2 Europe Transdermal Drug Patches Sales Market Share by Type (2015-2020)
7.3 Europe Transdermal Drug Patches Sales Market Share by Application (2015-2020)

8 China Transdermal Drug Patches Market Facts & Figures
8.1 China Transdermal Drug Patches Sales Market Share by Company (2015-2020)
8.2 China Transdermal Drug Patches Sales Market Share by Type (2015-2020)
8.3 China Transdermal Drug Patches Sales Market Share by Application (2015-2020)

9 Japan Transdermal Drug Patches Market Facts & Figures
9.1 Japan Transdermal Drug Patches Sales Market Share by Company (3015-3030)
9.2 Japan Transdermal Drug Patches Sales Market Share by Type (2015-2020)
9.3 Japan Transdermal Drug Patches Sales Market Share by Application (2015-2020)

10 Southeast Asia Transdermal Drug Patches Market Facts & Figures
10.1 Southeast Asia Transdermal Drug Patches Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Transdermal Drug Patches Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Transdermal Drug Patches Sales Market Share by Application (2015-2020)

11 India Transdermal Drug Patches Market Facts & Figures
11.1 India Transdermal Drug Patches Sales Market Share by Company (2015-2020)
11.2 India Transdermal Drug Patches Sales Market Share by Type (2015-2020)
11.3 India Transdermal Drug Patches Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Transdermal Drug Patches Business
12.1 Noven
12.1.1 Noven Corporation Information
12.1.2 Noven Business Overview
12.1.3 Noven Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Noven Transdermal Drug Patches Products Offered
12.1.5 Noven Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Business Overview
12.2.3 Mylan Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mylan Transdermal Drug Patches Products Offered
12.2.5 Mylan Recent Development
12.3 Novartis
12.3.1 Novartis Corporation Information
12.3.2 Novartis Business Overview
12.3.3 Novartis Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novartis Transdermal Drug Patches Products Offered
12.3.5 Novartis Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Business Overview
12.4.3 Johnson & Johnson Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Transdermal Drug Patches Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Agile Therapeutics
12.5.1 Agile Therapeutics Corporation Information
12.5.2 Agile Therapeutics Business Overview
12.5.3 Agile Therapeutics Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Agile Therapeutics Transdermal Drug Patches Products Offered
12.5.5 Agile Therapeutics Recent Development
12.6 Teikoku Pharma USA
12.6.1 Teikoku Pharma USA Corporation Information
12.6.2 Teikoku Pharma USA Business Overview
12.6.3 Teikoku Pharma USA Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Teikoku Pharma USA Transdermal Drug Patches Products Offered
12.6.5 Teikoku Pharma USA Recent Development
12.7 Immune Pharmaceuticals
12.7.1 Immune Pharmaceuticals Corporation Information
12.7.2 Immune Pharmaceuticals Business Overview
12.7.3 Immune Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Immune Pharmaceuticals Transdermal Drug Patches Products Offered
12.7.5 Immune Pharmaceuticals Recent Development
12.8 Hercon Pharmaceuticals
12.8.1 Hercon Pharmaceuticals Corporation Information
12.8.2 Hercon Pharmaceuticals Business Overview
12.8.3 Hercon Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hercon Pharmaceuticals Transdermal Drug Patches Products Offered
12.8.5 Hercon Pharmaceuticals Recent Development
12.9 Pocono
12.9.1 Pocono Corporation Information
12.9.2 Pocono Business Overview
12.9.3 Pocono Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Pocono Transdermal Drug Patches Products Offered
12.9.5 Pocono Recent Development
12.10 DURECT Corporation
12.10.1 DURECT Corporation Corporation Information
12.10.2 DURECT Corporation Business Overview
12.10.3 DURECT Corporation Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.10.4 DURECT Corporation Transdermal Drug Patches Products Offered
12.10.5 DURECT Corporation Recent Development
12.11 Xel Pharmaceuticals
12.11.1 Xel Pharmaceuticals Corporation Information
12.11.2 Xel Pharmaceuticals Business Overview
12.11.3 Xel Pharmaceuticals Transdermal Drug Patches Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Xel Pharmaceuticals Transdermal Drug Patches Products Offered
12.11.5 Xel Pharmaceuticals Recent Development

13 Transdermal Drug Patches Manufacturing Cost Analysis
13.1 Transdermal Drug Patches Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Transdermal Drug Patches
13.4 Transdermal Drug Patches Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Transdermal Drug Patches Distributors List
14.3 Transdermal Drug Patches Customers

15 Market Dynamics
15.1 Transdermal Drug Patches Market Trends
15.2 Transdermal Drug Patches Opportunities and Drivers
15.3 Transdermal Drug Patches Market Challenges
15.4 Transdermal Drug Patches Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Transdermal Drug Patches Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Transdermal Drug Patches Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Transdermal Drug Patches Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Transdermal Drug Patches Sales (K Units) by Region (2015-2020)
Table 5. Global Transdermal Drug Patches Sales Market Share by Region (2015-2020)
Table 6. Global Transdermal Drug Patches Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Transdermal Drug Patches Revenue Share by Region (2015-2020)
Table 8. Global Transdermal Drug Patches Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Transdermal Drug Patches Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Transdermal Drug Patches Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Transdermal Drug Patches Revenue Share Forecast by Region (2021-2026)
Table 12. Global Transdermal Drug Patches (K Units) of Key Companies (2015-2020)
Table 13. Global Transdermal Drug Patches Sales Share by Company (2015-2020)
Table 14. Global Transdermal Drug Patches Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Transdermal Drug Patches Revenue Share by Company (2015-2020)
Table 16. Global Transdermal Drug Patches by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Patches as of 2019)
Table 17. Global Transdermal Drug Patches Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Transdermal Drug Patches Manufacturing Sites and Area Served
Table 19. Manufacturers Transdermal Drug Patches Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Transdermal Drug Patches Players
Table 22. Global Transdermal Drug Patches Sales (K Units) by Type (2015-2020)
Table 23. Global Transdermal Drug Patches Sales Share by Type (2015-2020)
Table 24. Global Transdermal Drug Patches Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Transdermal Drug Patches Price (K Units) by Type (2015-2020)
Table 26. Global Transdermal Drug Patches Sales Share by Type (2021-2026)
Table 27. Global Transdermal Drug Patches Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Transdermal Drug Patches Revenue Share by Type (2021-2026)
Table 29. Global Transdermal Drug Patches Price (K Units) by Type (2021-2026)
Table 30. Global Transdermal Drug Patches Sales (K Units) by Application (2015-2020)
Table 31. Global Transdermal Drug Patches Sales Share by Application (2015-2020)
Table 32. Global Transdermal Drug Patches Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Transdermal Drug Patches Price (K Units) by Application (2015-2020)
Table 34. Global Transdermal Drug Patches Sales (K Units) by Application (2021-2026)
Table 35. Global Transdermal Drug Patches Sales Share by Application (2021-2026)
Table 36. Global Transdermal Drug Patches Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Transdermal Drug Patches Revenue Share by Application (2021-2026)
Table 38. Global Transdermal Drug Patches Price (K Units) by Application (2021-2026)
Table 39. United States Transdermal Drug Patches Sales (K Units) by Company (2015-2020)
Table 40. United States Transdermal Drug Patches Sales Market Share by Company (2015-2020)
Table 41. United States Transdermal Drug Patches Sales (K Units) by Type (2015-2020)
Table 42. United States Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 43. United States Transdermal Drug Patches Sales (K Units) by Application (2015-2020)
Table 44. United States Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 45. Europe Transdermal Drug Patches Sales (K Units) by Company (2015-2020)
Table 46. Europe Transdermal Drug Patches Sales Market Share by Company (2015-2020)
Table 47. Europe Transdermal Drug Patches Sales (K Units) by Type (2015-2020)
Table 48. Europe Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 49. Europe Transdermal Drug Patches Sales (K Units) by Application (2015-2020)
Table 50. Europe Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 51. China Transdermal Drug Patches Sales (K Units) by Company (2015-2020)
Table 52. China Transdermal Drug Patches Sales Market Share by Company (2015-2020)
Table 53. China Transdermal Drug Patches Sales (K Units) by Type (2015-2020)
Table 54. China Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 55. China Transdermal Drug Patches Sales (K Units) by Application (2015-2020)
Table 56. China Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 57. Japan Transdermal Drug Patches Sales (K Units) by Company (2015-2020)
Table 58. Japan Transdermal Drug Patches Sales Market Share by Company (2015-2020)
Table 59. Japan Transdermal Drug Patches Sales (K Units) by Type (2015-2020)
Table 60. Japan Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 61. Japan Transdermal Drug Patches Sales (K Units) by Application (2015-2020)
Table 62. Japan Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Transdermal Drug Patches Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Transdermal Drug Patches Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Transdermal Drug Patches Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Transdermal Drug Patches Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 69. India Transdermal Drug Patches Sales (K Units) by Company (2015-2020)
Table 70. India Transdermal Drug Patches Sales Market Share by Company (2015-2020)
Table 71. India Transdermal Drug Patches Sales (K Units) by Type (2015-2020)
Table 72. India Transdermal Drug Patches Sales Market Share by Type (2015-2020)
Table 73. India Transdermal Drug Patches Sales (K Units) by Application (2015-2020)
Table 74. India Transdermal Drug Patches Sales Market Share by Application (2015-2020)
Table 75. Noven Corporation Information
Table 76. Noven Description and Business Overview
Table 77. Noven Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Noven Transdermal Drug Patches Product
Table 79. Noven Recent Development
Table 80. Mylan Corporation Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Mylan Transdermal Drug Patches Product
Table 84. Mylan Recent Development
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Novartis Transdermal Drug Patches Product
Table 89. Novartis Recent Development
Table 90. Johnson & Johnson Corporation Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Johnson & Johnson Transdermal Drug Patches Product
Table 94. Johnson & Johnson Recent Development
Table 95. Agile Therapeutics Corporation Information
Table 96. Agile Therapeutics Description and Business Overview
Table 97. Agile Therapeutics Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Agile Therapeutics Transdermal Drug Patches Product
Table 99. Agile Therapeutics Recent Development
Table 100. Teikoku Pharma USA Corporation Information
Table 101. Teikoku Pharma USA Description and Business Overview
Table 102. Teikoku Pharma USA Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Teikoku Pharma USA Transdermal Drug Patches Product
Table 104. Teikoku Pharma USA Recent Development
Table 105. Immune Pharmaceuticals Corporation Information
Table 106. Immune Pharmaceuticals Description and Business Overview
Table 107. Immune Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Immune Pharmaceuticals Transdermal Drug Patches Product
Table 109. Immune Pharmaceuticals Recent Development
Table 110. Hercon Pharmaceuticals Corporation Information
Table 111. Hercon Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Hercon Pharmaceuticals Description and Business Overview
Table 113. Hercon Pharmaceuticals Transdermal Drug Patches Product
Table 114. Hercon Pharmaceuticals Recent Development
Table 115. Pocono Corporation Information
Table 116. Pocono Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Pocono Description and Business Overview
Table 118. Pocono Transdermal Drug Patches Product
Table 119. Pocono Recent Development
Table 120. DURECT Corporation Corporation Information
Table 121. DURECT Corporation Description and Business Overview
Table 122. DURECT Corporation Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. DURECT Corporation Transdermal Drug Patches Product
Table 124. DURECT Corporation Recent Development
Table 125. Xel Pharmaceuticals Corporation Information
Table 126. Xel Pharmaceuticals Description and Business Overview
Table 127. Xel Pharmaceuticals Transdermal Drug Patches Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Xel Pharmaceuticals Transdermal Drug Patches Product
Table 129. Xel Pharmaceuticals Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Transdermal Drug Patches Distributors List
Table 133. Transdermal Drug Patches Customers List
Table 134. Transdermal Drug Patches Market Key Trends
Table 135. Transdermal Drug Patches Key Opportunities and Drivers
Table 136. Transdermal Drug Patches Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Drug Patches Product Picture
Figure 2. Global Transdermal Drug Patches Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Transdermal Drug Patches Market Share by Application in 2020 & 2026
Figure 6. Used for Hypertension Examples
Figure 7. Used for Contraception Examples
Figure 8. Used for Analgesia Examples
Figure 9. Used for Smoking Cessation Examples
Figure 10. Used for Angina Examples
Figure 11. Used for Hormone Replacement Examples
Figure 12. Global Transdermal Drug Patches Sales (K Units) Growth Rate (2015-2026)
Figure 13. Global Transdermal Drug Patches Revenue (US$ Million) Growth Rate (2015-2026)
Figure 14. Global Transdermal Drug Patches Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 15. Global Transdermal Drug Patches Revenue Market Share by Region: 2015 VS 2020
Figure 16. Global Transdermal Drug Patches Revenue Market Share by Region: 2021 VS 2026
Figure 17. United States Transdermal Drug Patches Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. United States Transdermal Drug Patches Sales (K Units) Growth Rate (2015-2026)
Figure 19. Europe Transdermal Drug Patches Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Europe Transdermal Drug Patches Sales (Million USD) Growth Rate (2015-2026)
Figure 21. China Transdermal Drug Patches Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. China Transdermal Drug Patches Sales (Million USD) and Growth Rate (2015-2026)
Figure 23. Japan Transdermal Drug Patches Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Japan Transdermal Drug Patches Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Transdermal Drug Patches Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. Southeast Asia Transdermal Drug Patches Sales (Million USD) Growth Rate (2015-2026)
Figure 27. India Transdermal Drug Patches Revenue (Million USD) Growth Rate (2015-2026)
Figure 28. India Transdermal Drug Patches Sales (Million USD) Growth Rate (2015-2026)
Figure 29. Global 5 Largest Transdermal Drug Patches Players Market Share by Revenue in Transdermal Drug Patches 2015 & 2019
Figure 30. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 31. Global Transdermal Drug Patches Revenue Share by Type (2015-2020)
Figure 32. Global Transdermal Drug Patches Revenue Growth Rate by Type in 2015 & 2019
Figure 33. Global Transdermal Drug Patches Revenue Share by Application (2015-2020)
Figure 34. Global Transdermal Drug Patches Revenue Growth Rate by Application in 2015 & 2019
Figure 35. United States Transdermal Drug Patches Sales Market Share by Type in 2019
Figure 36. United States Transdermal Drug Patches Sales Market Share by Type in 2019
Figure 37. Europe Transdermal Drug Patches Sales Market Share by Company in 2019
Figure 38. Europe Transdermal Drug Patches Sales Market Share by Type in 2019
Figure 39. Europe Transdermal Drug Patches Sales Market Share by Application in 2019
Figure 40. China Transdermal Drug Patches Sales Market Share by Company in 2019
Figure 41. China Transdermal Drug Patches Sales Market Share by Type in 2019
Figure 42. China Transdermal Drug Patches Sales Market Share by Application in 2019
Figure 43. Japan Transdermal Drug Patches Sales Market Share by Company in 2019
Figure 44. Japan Transdermal Drug Patches Sales Market Share by Type in 2019
Figure 45. Japan Transdermal Drug Patches Sales Market Share by Application in 2019
Figure 46. Southeast Asia Transdermal Drug Patches Sales Market Share by Company in 2019
Figure 47. Southeast Asia Transdermal Drug Patches Sales Market Share by Type in 2019
Figure 48. Southeast Asia Transdermal Drug Patches Sales Market Share by Application in 2019
Figure 49. India Transdermal Drug Patches Sales Market Share by Company in 2019
Figure 50. India Transdermal Drug Patches Sales Market Share by Type in 2019
Figure 51. India Transdermal Drug Patches Sales Market Share by Application in 2019
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Transdermal Drug Patches
Figure 54. Manufacturing Process Analysis of Transdermal Drug Patches
Figure 55. Transdermal Drug Patches Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Porter's Five Forces Analysis
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed